John J. Orloff is VP at ALEXION PHARMACEUTICALS, INC. (ALXN). They have made 1 open-market trade across 1 company since 2018, most recently 2021-07-21.
CIK 0001643941
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2018-06-08 | 2018-06-12 | $118.53 | $501K | +8.5% | +14.2% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.